PRINCIPALS OF CPMI
Historically, our management team's collaborative spirit, diverse education, experience, knowledge, skills. and integrity have complemented each other to make an exceptional research team.

KENNETH C. LASSETER , MD, Vice President and Medical Director 
DOWNLOAD CV
Dr Lasseter is a clinical pharmacologist certified by the American Board of Clinical Pharmacology. He also had residency training and is board eligible in Cardiology and Internal Medicine. His research career started on the faculty of the University of Miami School of Medicine where he and E. Cooper Shamblen developed a Clinical Pharmacology Research Unit.

In 1977, they founded Clinical Pharmacology Associates, inc. (CPA) and opened one of the first research units in the private sector. CPA became one of the most successful such units in the burgeoning CRO industry. Stacy C Dilzer, R.N., BSN, joined them and became the clinical director and operational head of the organization.

In 2003, CPA merged to form the largest free standing clinical pharmacology research unit in the world. This organization ceased Phase I research business in the United States in 2006 and the idea for Clinical Pharmacology of Miami, Inc was spawned from the real need for a high quality clinical pharmacology research unit.

Dr Lasseter, Stacy Dilzer and Cooper Shamblen have a combined 90+ years of research experience and have conducted over 1200 clinical studies. Dr Lasseter has published over 250 articles and abstracts in the areas of Clinical Pharmacology, reporting the work that they have done. Dr. Lasseter truly has a national and international reputation as an outstanding clinical pharmacologist and Principal Investigator.

STACY C. DILZER, R.N., BSN, President  
DOWNLOAD CV
Stacy is a State of Florida registered nurse. She has over 20 years of experience in the clinical research field. Her positions have included study coordinator, project manager, director of clinical operations, chief compliance officer and vice president of clinical operations. She has been the primary contact for the Food and Drug audit teams and sponsoring institution audit teams for the past 15 years, hosting numerous FDA and sponsor audits, managing phase I-IV clinical trials including bio availability and pharmacokinetic studies in special populations and in normal subjects.

E. COOPER SHAMBLEN, Chief Executive Officer  
DOWNLOAD CV
Cooper Started his pharmaceutical career in sales and was a successful sales force manager for a major pharmaceutical company. His research career started as an Adjunct Assistant Professor at the University of Miami School of Medicine, Department of Pharmacology. In 1977, he and Kenneth C. Lasseter, MD founded Clinical Pharmacology Associates. That experience has laid the foundation for this Clinical Pharmacology Research Unit.